Athira Pharma has been on a bumpy road in recent years, and now the company is restructuring and shedding weight to try to ...
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...
Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.
Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty ...
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical ...
Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.
Suggested remit: To appraise the clinical and cost effectiveness of tofersen within its marketing authorisation for treating amyotrophic lateral sclerosis caused by superoxide dismutase 1 (SOD1) ...
1d
US Weekly on MSNPrince William, Kate Middleton Support Book About Late Rugby Star With ALSPrince William and Kate Middleton have offered their support to Lindsey Burrow, the widow of late British rugby star Rob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results